Treatment of Executive Dysfunction in Parkinson's Disease

NCT00286949 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Atomoxetine

Sponsor

Johns Hopkins University

Collaborators

[object Object]